ADHF clinical trials at UCSF

1 research study open to eligible people

Acute decompensated heart failure, or ADHF, is when heart failure symptoms quickly become severe. UCSF is conducting research on the Aortix device for patients hospitalized with heart issues. This study looks at whether Aortix is more effective than just using diuretics.

Showing trials for

  • Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

    open to eligible people ages 21 years and up

    Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) and have persistent congestion despite usual medical therapy. Eligible ADHF patients with diuretic resistance (irrespective of ejection fraction) will be enrolled and randomized 1:1 to either the Aortix system or standard of care medical management.

    San Francisco, California and other locations

Last updated: